Thursday, September 26, 2013

Phun Phacts about Pharma Phraud Phines

›
Thanks to my most recent issue of the newsletter of the Physicians for a National Health Program (my full disclosure regarding my socialis...
Wednesday, September 25, 2013

How to Tell Good from Bad Guidelines, and More on Conflicts of Interest

›
A recently released paper in the BMJ (subscription will soon be required but apparently it’s openly available for a limited time): htt...
Monday, September 16, 2013

Science vs. Trade Secrets: Can Pharma Tell the Difference?

›
Dr. Roy Poses at Health Care Renewal first called this matter to my attention, but Dr. Poses in turn cites two posts from the “1 Boring ...
1 comment:
Saturday, September 7, 2013

An Update on KOLs

›
In the previous post I mentioned a collection of essays on institutional corruption in Pharma. One of the essays: http://papers.ssrn.com/so...
Friday, September 6, 2013

Special Journal Issue, “Institutional Corruption and Pharmaceutical Policy”

›
I’m happy to turn the podium over to Professor Marc Rodwin, who a while back sent me the message below, which I managed to put aside at ...
Tuesday, September 3, 2013

Gene Patenting: What Did the Supreme Court Rule in Myriad?

›
I forget what I was doing back in the late spring when the US Supreme Court issued a couple of major rulings on issues of interest to th...
Sunday, September 1, 2013

Why There's No Such Thing as Conflict of Interest

›
A good deal of this blog is about conflicts of interest at the interface between medicine and the pharmaceutical industry, and we occasional...